The increasing role of amphiregulin in non-small cell lung cancer

被引：14
作者：
Busser, B. [1 ,2 ]
Coll, J. -L. [1 ]
Hurbin, A. [1 ]
机构：
[1] Univ Grenoble 1, INSERM, U823, Inst Albert Bonniot, F-38042 Grenoble 9, France
[2] CHRU, Hop Michallon, UF Cancerol Biol & Biotherapie, F-38000 Grenoble, France
来源：
PATHOLOGIE BIOLOGIE | 2009年 / 57卷 / 7-8期
关键词：
Amphiregulin; Non-small cell lung cancer; Gefitinib; Growth factor; Apoptosis; Drug resistance; EGFR; Targeted therapy; Tyrosine kinase inhibitors; DEPENDENT PATHWAY; GROWTH; APOPTOSIS;
D O I：
10.1016/j.patbio.2008.10.002
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：511 / 512
页数：2
相关论文
共 50 条
[41]   Notch signaling and non-small cell lung cancer (Review) [J].
Zou, Bin ;
Zhou, Xue-Liang ;
Lai, Song-Qing ;
Liu, Ji-Chun .
ONCOLOGY LETTERS, 2018, 15 (03) :3415-3421
[42]   Molecular therapeutic targets in non-small cell lung cancer [J].
Sankar, Kamya ;
Gadgeel, Shirish M. ;
Qin, Angel .
EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (08) :647-661
[43]   Tepotinib hydrochloride for the treatment of non-small cell lung cancer [J].
Wu, Z-X ;
Li, J. ;
Dong, S. ;
Lin, L. ;
Zou, C. ;
Chen, Z-S .
DRUGS OF TODAY, 2021, 57 (04) :265-275
[44]   Safety of gefitinib in non-small cell lung cancer treatment [J].
Hsiue, Emily Han-Chung ;
Lee, Jih-Hsiang ;
Lin, Chia-Chi ;
Yang, James Chih-Hsin .
EXPERT OPINION ON DRUG SAFETY, 2016, 15 (07) :993-1000
[45]   Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer [J].
Sirhan, Zaid ;
Alojair, Rawan ;
Thyagarajan, Anita ;
Sahu, Ravi P. .
PHARMACEUTICS, 2023, 15 (08)
[46]   Personalized treatment of advanced non-small cell lung cancer [J].
Koehler, J. ;
Schuler, M. .
ONKOLOGE, 2011, 17 (08) :702-+
[47]   EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer [J].
Gerber, David E. .
DRUG DEVELOPMENT RESEARCH, 2008, 69 (06) :359-372
[48]   Antiangiogenic drugs in non-small cell lung cancer treatment [J].
Cascone, T ;
Troiani, T ;
Morelli, MP ;
Gridelli, C ;
Ciardiello, F .
CURRENT OPINION IN ONCOLOGY, 2006, 18 (02) :151-155
[49]   BATF acts as an oncogene in non-small cell lung cancer [J].
Feng, Yu ;
Pan, Liangbin ;
Zhang, Biao ;
Huang, Haitao ;
Ma, Haitao .
ONCOLOGY LETTERS, 2020, 19 (01) :205-210
[50]   Experience with erlotinib in the treatment of non-small cell lung cancer [J].
Landi, Lorenza ;
Cappuzzo, Federico .
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (04) :146-163
12345